Dr. Kumar importantly has shown a strong track record of publications in renowned journals including JACS, Advanced Materials, Biomaterials Science and Biomaterials; with independent funding from the AHA and NIH. Dr. Kumar will lead the company in research affairs.
Dr. Vivek Kumar, PhDadmin
Chief Executive Officer
Over the past decade, Dr. Kumar has honed his skills in the fields of inflammation and angiogenesis. His research in vascular grafts was with Elliot Chaikof, M.D., Ph.D, at Georgia Tech, Emory, and subsequently at BIDMC, Harvard Medical School. In the Hartgerink lab, Dr. Kumar co-invented the materials being commercialized at NangioTx, performed initial safety and bio-distribution studies in mice and rats, and has been a driving force for the translation of these materials.